Celgene lawyer, scientist preview bids to dismiss antitrust claims in proposed US class action over multiple-myeloma drug
Attorneys for a former Celegne lawyer and scientist persuaded a US federal judge today to allow the two named defendants an opportunity to file separate motions to dismiss what they called...To view the full article, register now.
Already a subscriber? Click here to view full article